Invitation to the presentation of Elekta's third quarter 2020/21
STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2020/21 at 10:00 a.m. CET on February 25. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day.
The company's development will be presented by Elekta's President and CEO Gustaf Salford together with acting CFO Johan Adebäck. After the presentation, held in English, a Q&A session will follow.
The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta's website after the call.
Time: Thursday, February 25, at 10:00 a.m. CET
Telephone numbers to join phone conference:
UK: +44 333 300 9264
USA: +1 833 526 8382
Sweden: +46 8 505 583 69
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: email@example.com
Time zone: CET (Central European Time)
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Upcoming Life Sciences Events
- May 2021
- Shanghai: ChinaBio® Partnering Forum
- European Health-tech Innovation Week
- 7th Annual Immuno-Oncology Innovation Forum
Latest company news
Vertex and CRISPR Therapeutics to Present New Clinical Data on Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ For Severe Hemoglobinopathies at the Annual European Hematology Association Virtual Congress